Using the 3D humanized scaffold xenograft model, originally proposed by the Bonnet group [25] to recapitulate physiological interactions between AML cells and different BM cell subpopulations, our study has demonstrated the inhibition of normal CD34 + cell expansion in AML [50]. The gene discussed is CD34; the disease is acute myeloid leukemia.